Report Detail
Asia Pacific Vaccines Market to 2027- Regional Analysis and Forecasts By Technology (Recombinant Vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated and Subunit Vaccines, and Toxoid Vaccines); Disease Indication (DTP (Diphtheria Tetanus toxoids and Pertussis), Influenza, Hepatitis, Respiratory Syncytial Virus (RSV), and Other Diseases); Route of Administration (Oral, Injectable, and Other Routes of Administration); Patient Type (Pediatric Patients, and Adult Patients), and Countr
- RnM3599562 |
- 16 July, 2019 |
- Global |
- 152 Pages |
- The Insight Partners |
- Pharma & Healthcare
The Asia Pacific vaccines market is expected to reach US$ 12,631.4 Mn in 2027 from US$ 7,254.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.4% from 2019-2027.
Every year thousands of children in Asia Pacific region die, and many more are hospitalized due to diseases which are preventable by vaccines. The treatment cost of these diseases is very high. According to the Gavi, the Vaccine Alliance, one in every five children in Asia Pacific region don’t have access to basic vaccines. Thus in Asia Pacific region, many awareness programs have been undertaken by the government in order to raise awareness among the population. The Immunization Partners in Asia Pacific (IPAP) arranged the 6th Asian Vaccine Conference (ASVAC 2017), in April 2017at Singapore. The countries in the Asia Pacific region are joining forces to eradicate infectious diseases like measles, diphtheria, rubella, pertussis, and others through vaccinations. There are several vaccination programs, campaigns, conferences, being held in the Asia Pacific region in order to raise awareness among the population. For instance, India, along with other WHO South East Asia Region member countries, has initiated a campaign to eradicate measles and control rubella/congenital rubella syndrome (CRS) by 2020. The campaigns by the Ministry of Health & Family Welfare aims to immunize 41 crore children in India. The first phase of the campaign was successfully completed in February 2017 in five states, namely, Tamil Nadu, Karnataka, Goa, Lakshadweep, and Puducherry. Over 3.3 crore children were vaccinated, reaching out to 97% of the targeted age group. The campaign was conducted in schools, community centers, and other health facilities.
In 2018, the conjugate vaccines segment held the largest market share of 27.2% of the vaccines market, by type. This segment is also expected to dominate the market in 2027 owing to the advantages offered by the vaccines for diseases such as pneumonia and others. Furthermore, the conjugate vaccines segment is anticipated to witness the significant growth rate during the forecast period, 2019 to 2027.
Asia Pacific vaccines market by the disease indication was led by the other segments, which has included diseases such as poliomyelitis (polio), measles, mumps, rubella, pneumococcal infections, and others. The others segment has the largest market share in 2018, which accounted for 59.6% and is expected to dominate the market in 2027. Similarly, the vaccines market by the route of administration was led by the injectable segment. Whereas, the market of the vaccines in the Asia Pacific by the patient type was led by the pediatric segment.
Some of the major primary and secondary sources for vaccines included in the report are Immunization Partners in Asia Pacific (IPAP), Food and Drug Administration, World Health Organization, National Polio Surveillance Project (NPSP), Global Alliance for Vaccines and Immunization (GAVI) and Others.
1. Introduction
- 1.1 Scope Of The Study
- 1.2 The Insight Partners Research Report Guidance
2. Asia Pacific Vaccines Market – Key Takeaways
3. Asia Pacific Vaccines Market – Market Landscape
- 3.1 Overview
- 3.2 Market Segmentation
- 3.2.1 Asia Pacific Vaccines Market – By Technology
- 3.2.2 Asia Pacific Market – By Disease Indication
- 3.2.3 Asia Pacific Vaccines Market – By Route Of Administration
- 3.2.4 Asia Pacific Vaccines Market – By Patient Type
- 3.2.5 Asia Pacific Vaccines Market – By Country
- 3.3 Pest Analysis
- 3.3.1 Asia Pacific– Pest Analysis
4. Asia Pacific Vaccines Market - Key Market Dynamics
- 4.1 Key Market Drivers
- 4.1.1 Rising Number Of Awareness Programs, Campaigns And Conferences For Vaccination In Asia Pacific
- 4.1.2 Growing Vaccine Production In Asia Pacific.
- 4.2 Key Market Restraints
- 4.2.1 Mistrust Of Immunization In The Asia Pacific Region.
- 4.3 Key Market Opportunities
- 4.3.1 Increasing Incidences Of Infectious And Contagious Diseases
- 4.4 Future Trends
- 4.4.1 Vaccine Research In Asia
- 4.5 Impact Analysis
5. Vaccines Market – Asia Pacific Analysis
- 5.1 Asia Pacific Vaccines Market Revenue Forecasts And Analysis
- 5.2 Market Positioning
- 5.3 Performance Of Key Players
- 5.3.1 GlaxoSmithKline Plc
6. Asia Pacific Vaccines Market Analysis – By Technology
- 6.1 Overview
- 6.2 Asia Pacific Vaccines Market, By Type, 2018 & 2027 (%)
- 6.3 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
- 6.4 Asia Pacific Recombinant Vaccines Market
- 6.4.1 Overview
- 6.4.2 Asia Pacific Recombinant Vaccines Market Revenue And Forecast To 2027 (US$ Mn)
- 6.5 Asia Pacific Conjugate Vaccines Market
- 6.5.1 Overview
- 6.5.2 Asia Pacific Conjugate Vaccines Market Revenue And Forecast To 2027 (US$ Mn)
- 6.6 Asia Pacific Live Attenuated Vaccines Market
- 6.6.1 Overview
- 6.6.2 Asia Pacific Live Attenuated Vaccines Market Revenue And Forecast To 2027 (US$ Mn)
- 6.7 Asia Pacific Inactivated Vaccines Market
- 6.7.1 Overview
- 6.7.2 Asia Pacific Inactivated Vaccines Market Revenue And Forecast To 2027 (US$ Mn)
- 6.8 Asia Pacific Toxoid Vaccines Market
- 6.8.1 Overview
- 6.8.2 Asia Pacific Toxoid Vaccines Market Revenue And Forecast To 2027 (US$ Mn)
7. Asia Pacific Vaccines Market Analysis – By Disease Indication
- 7.1 Overview
- 7.2 Asia Pacific Vaccines Market, By Disease Indication, 2018 & 2027 (%)
- 7.3 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
- 7.4 Asia Pacific DTP (Diphtheria, Tetanus, And Pertussis) Market
- 7.4.1 Overview
- 7.4.2 Asia Pacific DTP (Diphtheria, Tetanus, And Pertussis) Market Revenue And Forecast To 2027 (US$ Mn)
- 7.5 Asia Pacific Influenza Market
- 7.5.1 Overview
- 7.5.2 Asia Pacific Influenza Market Revenue And Forecast To 2027 (US$ Mn)
- 7.6 Asia Pacific Hepatitis Market
- 7.6.1 Overview
- 7.6.2 Asia Pacific Hepatitis Market Revenue And Forecast To 2027 (US$ Mn)
- 7.7 Asia Pacific Other Diseases Market
- 7.7.1 Overview
- 7.7.2 Asia Pacific Other Diseases Market Revenue And Forecast To 2027 (US$ Mn)
8. Asia Pacific Vaccines Market Analysis – By Route Of Administration
- 8.1 Overview
- 8.2 Asia Pacific Vaccines Market, By Route Of Administration, 2018 & 2027 (%)
- 8.3 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
- 8.4 Asia Pacific Oral Market
- 8.4.1 Overview
- 8.4.2 Asia Pacific Oral Market Revenue And Forecast To 2027 (US$ Mn)
- 8.5 Asia Pacific Injectable Market
- 8.5.1 Overview
- 8.5.2 Asia Pacific Injectable Market Revenue And Forecast To 2027 (US$ Mn)
- 8.6 Asia Pacific Other Routes Of Administration Market
- 8.6.1 Overview
- 8.6.2 Asia Pacific Other Routes Of Administration Market Revenue And Forecast To 2027 (US$ Mn)
9. Asia Pacific Vaccines Market Analysis – By Patient Type
- 9.1 Overview
- 9.2 Asia Pacific Vaccines Market, By Patient Type, 2018 & 2027 (%)
- 9.3 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
- 9.4 Asia Pacific Pediatric Market
- 9.4.1 Overview
- 9.4.2 Asia Pacific Pediatric Market Revenue And Forecast To 2027 (US$ Mn)
- 9.5 Asia Pacific Adults Market
- 9.5.1 Overview
- 9.5.2 Asia Pacific Adults Market Revenue And Forecast To 2027 (US$ Mn)
10. Asia Pacific Vaccines Market Revenue And Forecasts To 2027
- 10.1.1 Overview
- 10.1.2 Asia Pacific Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.3 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
- 10.1.4 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
- 10.1.5 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
- 10.1.6 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
- 10.1.7 Asia Pacific Vaccines Market Revenue And Forecasts To 2027, By Country (%)
- 10.1.8 China Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.9 China Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.9.1 China Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
- 10.1.9.2 China Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
- 10.1.9.3 China Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
- 10.1.9.4 China Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
- 10.1.10 Japan Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.11 Japan Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.11.1 Japan Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
- 10.1.11.2 Japan Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
- 10.1.11.3 Japan Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
- 10.1.11.4 Japan Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
- 10.1.12 India Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.13 India Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.13.1 India Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
- 10.1.13.2 India Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
- 10.1.13.3 India Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
- 10.1.13.4 India Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
- 10.1.14 Australia Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.15 Australia Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.15.1 Australia Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
- 10.1.15.2 Australia Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
- 10.1.15.3 Australia Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
- 10.1.15.4 Australia Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
- 10.1.16 South Korea Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.17 South Korea Vaccines Market Revenue And Forecasts To 2027 (US$ Mn)
- 10.1.17.1 South Korea Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
- 10.1.17.2 South Korea Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)
- 10.1.17.3 South Korea Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)
- 10.1.17.4 South Korea Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)
11. Vaccines Market–Key Company Profiles
- 11.1 Pfizer Inc.
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Financial Overview
- 11.1.4 Product Portfolio
- 11.1.5 Swot Analysis
- 11.1.6 Key Developments
- 11.2 GlaxoSmithKline Plc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Financial Overview
- 11.2.4 Product Portfolio
- 11.2.5 Swot Analysis
- 11.2.6 Key Developments
- 11.3 Merck & Co., Inc.
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Financial Overview
- 11.3.4 Product Portfolio
- 11.3.5 Swot Analysis
- 11.3.6 Key Developments
- 11.4 Sanofi
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Financial Information
- 11.4.4 Product Portfolio
- 11.4.5 Swot Analysis
- 11.4.6 Key Developments
- 11.5 Johnson & Johnson Services, Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Financial Overview
- 11.5.4 Product Portfolio
- 11.5.5 Swot Analysis
- 11.5.6 Key Developments
- 11.6 Panacea Biotic Limited
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Financial Information
- 11.6.4 Product Portfolio
- 11.6.5 Swot Analysis
- 11.6.6 Key Developments
- 11.7 Astellas Pharma Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Financial Overview
- 11.7.4 Product Portfolio
- 11.7.5 Swot Analysis
- 11.7.6 Key Developments
- 11.8 Novavax, Inc.
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Financial Information
- 11.8.4 Product Pipeline
- 11.8.5 Swot Analysis
- 11.8.6 Key Developments
- 11.9 VBI Vaccines Inc.
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Financial Information
- 11.9.4 Product Portfolio
- 11.9.5 Swot Analysis
- 11.9.6 Key Developments
- 11.10 Bavarian Nordic
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Financial Information
- 11.10.4 Product Pipeline
- 11.10.5 Swot Analysis
- 11.10.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary Of Terms
- 12.3 Methodology
- 12.3.1 Coverage
- 12.3.2 Secondary Research
Summary:
Get latest Market Research Reports on Asia Pacific Vaccines . Industry analysis & Market Report on Asia Pacific Vaccines is a syndicated market report, published as Asia Pacific Vaccines Market to 2027- Regional Analysis and Forecasts By Technology (Recombinant Vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated and Subunit Vaccines, and Toxoid Vaccines); Disease Indication (DTP (Diphtheria Tetanus toxoids and Pertussis), Influenza, Hepatitis, Respiratory Syncytial Virus (RSV), and Other Diseases); Route of Administration (Oral, Injectable, and Other Routes of Administration); Patient Type (Pediatric Patients, and Adult Patients), and Countr. It is complete Research Study and Industry Analysis of Asia Pacific Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
